Autism Spectrum Disorders: Clinical Trials

5 trials for Autism Spectrum Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 5

Follow Autism Spectrum Disorders: new trials by email Literature Review of Autism Spectrum Disorders trials Research Report on Autism Spectrum Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders
Syntocinon (Oxytocin), Placebo (Physiological water (solution of sodium chloride (NaCl) in water)) - Autism Spectrum Disorders
Phase 4CompletedKU Leuven402015-04-012021-02-10
Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism
ABA parent training - Autism Spectrum Disorders
Phase 4CompletedFederal University of São Paulo672014-02-012015-04-02
Omega-3 Fatty Acids in Autism Spectrum Disorders
Omega-3 fatty acids - Autism Spectrum Disorders
Phase 4CompletedNational Healthcare Group, Singapore602011-09-012013-05-01
A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
Memantine - Autism Spectrum Disorders
Phase 4CompletedMassachusetts General Hospital252010-01-012024-07-01
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
Metformin - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedCambridge Health Alliance112006-07-012010-03-25

Narrower conditions

Autism Spectrum Disorder (5)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Child Development Disorders, Pervasive (1)  ·  Obesity (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Weight Gain (1)

Broader conditions

Mental Disorders (5)  ·  Neurodevelopmental Disorders (5)  ·  Child Development Disorders, Pervasive (4)  ·  Bipolar and Related Disorders (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Mood Disorders (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Signs and Symptoms (1)

Interventions

Fatty Acids, Omega-3 (1)  ·  Memantine (1)  ·  Metformin (1)  ·  Oxytocin (1)

Sponsors

Cambridge Health Alliance (1)  ·  Federal University of São Paulo (1)  ·  KU Leuven (1)  ·  Massachusetts General Hospital (1)  ·  National Healthcare Group, Singapore (1)

Countries

United States (2)  ·  Brazil (1)  ·  Singapore (1)

Top investigators

Gagan Joshi, MD (1)  ·  Jean A Frazier, MD (1)  ·  Kaat Alaerts, PhD (1)  ·  Min Sung, MBBS, MMed (1)  ·  Sheila C Caetano, MD, PhD (1)

Results publications

PMID 36808953, PMID 37811711

NIH funding

2014 (1)